Dicerna Pharmaceuticals (DRNA) PT Lowered to $25 at Citi
Tweet
Share
E-mailGet Alerts DRNA Hot Sheet
Price: $38.22 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Dicerna Pharmaceuticals (NASDAQ: DRNA) to $25.00 (from $30.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
